29.07.2011 • News

Linde H1 Earnings Up

Linde Group's six-month earnings attributable to Linde AG shareholders after adjusting for non-controlling interests advanced to €566 million from €445 million last year. Earnings after tax rose 23.8% to €598 million from €483 million a year ago.

In the first half of 2011, group sales improved 11% to €6.77 billion from €6.10 billion in the comparable period a year ago. After adjusting for exchange rate effects, the increase in sales was 10.3%.

Earnings per share grew by 26.2% to €3.32 from €2.63 a year earlier. On an adjusted basis, after adjusting for the effects of the purchase price allocation from the 2006 BOC acquisition, earnings per share stood at €3.79 compared with €3.15 in 2010.

The company confirmed its outlook and expects to achieve growth in group sales and group operating profit in the 2011 financial year compared with the prior year.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.